SITI WEB ITALIA

CATALOGARE

Informazioni sul dominio e sul sito Web:

carsol.it



English

Informazioni sul sito:


Nome del dominio - carsol.it


Titolo del sito - carsol.it


Vai al sito web - carsol.it



Le parole migliori contano carsol.it:

dominio - 8
rate - 4
per - 4
può - 4
pagamento - 3
con - 3
venditore - 3
carsol - 2
vendita - 2
anche - 2

Vedi l'elenco completo delle parole



Posizione GEO del sito


Posizione Paese - Italy



Città/Paese - Rome



Fornitore - Server Plan S.r.l.




carsol.it Posizione GEO sulla mappa


Site Logo



There is no Open Graph data at carsol.it




Informazioni per il dominio carsol.it


indirizzo IP:


185.81.6.55


Server dei nomi di dominio:


ns3.nicomed.it ns4.nicomed.it


Tutti i record:


☆ carsol.it. 2581 IN TXT "v=spf1 +a +mx +ip4:185.81.6.55 ~all"
☆ carsol.it. 2581 IN MX 0 carsol.it.
☆ carsol.it. 13381 IN SOA ns3.nicomed.it. cpanel_notice.notifiche.serverplan.com. 2024051200 3600 1800 1209600 86400
☆ carsol.it. 13381 IN NS ns4.nicomed.it.
☆ carsol.it. 13381 IN NS ns3.nicomed.it.
☆ carsol.it. 2581 IN A 185.81.6.55


Informazioni sul server Whois per carsol.it



Brief facts about carsol:

Carbamazepine, sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain. It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder. Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures. It is not effective for absence or myoclonic seizures. Carbamazepine was discovered in 1953 by Swiss chemist Walter Schindler. It was first marketed in 1962. It is available as a generic medication. It is on the World Health Organization's List of Essential Medicines. In 2020, it was the 185th most commonly prescribed medication in the United States, with more than 2 million prescriptions. Photoswitchable analogues of carbamazepine have been developed to control its pharmacological activity locally and on demand using light, with the purpose to reduce adverse systemic effects.

Mood stabilizers

Dibenzazepines

Anticonvulsants

Ureas

Prodrugs

GABAA receptor positive allosteric modulators

World Health Organization essential medicines

 

© DMS 2011-